Understanding the 1986 and 1993 Tax Reform Acts in the US
Finance

Understanding the 1986 and 1993 Tax Reform Acts in the US

authorBy Lisa Jing
DateApr 29, 2026
Read time3 min

The Tax Reform Act of 1986 marked a significant overhaul of the United States income tax system, striving for greater simplicity and equity. This legislation reduced the highest individual income tax bracket and aligned the taxation of long-term capital gains with ordinary income rates. It also eliminated numerous tax shelters and modified various deductions. Building upon this, the Tax Reform Act of 1993, introduced during the Clinton administration, brought further changes. It increased tax rates for specific high-income earners and corporations, while also removing some deductions, notably the tax ceiling on Medicare contributions. Together, these acts represent pivotal moments in American fiscal policy, shaping the economic landscape for individuals and businesses alike.

The Tax Reform Act of 1986, enacted on October 22, 1986, under President Ronald Reagan, was primarily designed to streamline the federal income tax code. A key objective was to foster economic growth by reducing the maximum tax rate on ordinary income from 50% to 28%. Simultaneously, the lowest tax rate saw a modest increase from 11% to 15%. This marked a historic shift, as it was the first instance in U.S. tax history where the highest tax rate was lowered while the lowest rate was raised.

A notable aspect of the 1986 Act was the elimination of the preferential treatment for long-term capital gains. Previously, capital gains were often taxed at lower rates or received partial exemptions. The new law stipulated that capital gains would be taxed at the same rate as ordinary income, effectively increasing the maximum tax rate on long-term capital gains from 20% to 28%. This change aimed to create a more unified and equitable tax structure.

Beyond rate adjustments, the 1986 Act also targeted various tax loopholes and deductions. It mandated that individuals claiming children as dependents must provide Social Security numbers for each child. It also expanded the Alternative Minimum Tax (AMT), ensuring that wealthier individuals and corporations paid a minimum amount of tax regardless of deductions. Conversely, it increased personal exemptions and standard deduction amounts, adjusted for inflation, to benefit a broader base of taxpayers. For businesses, the corporate tax rate was lowered from 50% to 35%, while allowances for certain business expenses, such as meals, travel, and entertainment, were reduced or restricted.

The Tax Reform Act of 1993, also known as the Revenue Reconciliation Act of 1993, introduced additional changes under President Bill Clinton's administration. This legislation created a new 36% tax bracket for high-income earners and imposed an additional 10% tax on married couples with incomes exceeding $250,000. It also increased taxes on Social Security benefits and removed the tax cap on Medicare contributions. The 1993 Act also raised corporate tax rates, extended the depreciation period for goodwill, and eliminated the deductibility of congressional lobbying expenses. A significant feature of this act was its retroactive application of increased tax rates to the beginning of the year, despite being signed into law in August, a move that generated considerable discussion.

In essence, the 1986 and 1993 tax reform acts collectively reshaped the U.S. tax system, influencing individual and corporate tax burdens, simplifying certain aspects of the tax code, and eliminating various deductions. These legislative efforts aimed to strike a balance between promoting economic growth, ensuring fairness, and addressing the nation's fiscal needs.

More Articles
Finance
Adlai Nortye: Pivoting to Early-Stage Oncology with Financial Reinforcement
Adlai Nortye has recalibrated its strategy after a Phase 3 setback, now focusing on promising early-stage RAS-targeting and immuno-oncology assets. Bolstered by recent financings and a payment from ASK Pharm, the company's financial position is robust. While AN9025 is a key strategic candidate, its early phase requires further clinical validation. The most advanced program, Palupiprant, appears to be a secondary focus. Despite a reasonable valuation, more data is needed to justify an upgrade to bullish sentiment.
By Michele FerreroApr 29, 2026
Finance
Meta's Stellar Quarter Overshadowed by Capex Concerns
Meta Platforms, Inc. (META) reported exceptional Q1 financial results, surpassing revenue and EPS estimates. However, the market reacted negatively due to a significant increase in the 2026 capital expenditure forecast, raising concerns about future profitability. Despite this, AI-driven advertising improvements contributed to a 12% year-over-year rise in average ad price, demonstrating strong monetization potential. The author maintains a $975 price target, confident in Meta's ability to sustain margins and capitalize on AI investments.
By Robert KiyosakiApr 29, 2026
Finance
Understanding Financial Intermediaries: Roles, Benefits, and Economic Impact
Financial intermediaries are pivotal entities in the financial system, bridging the gap between savers and borrowers. They facilitate capital allocation, reduce transaction costs through economies of scale, and manage risks through diversification. This article explores their functions, diverse types, advantages, and significant contributions to economic stability, highlighting their essential role in fostering investment and business growth.
By David RubensteinApr 29, 2026
Finance
Understanding Layoffs: Causes, Impact, and Employee Rights
This article explores the concept of layoffs, distinguishing them from furloughs and firings, and delves into their causes, economic impact, and the support available to affected individuals. It also examines the broader implications of mass layoffs on employees, communities, and businesses.
By Morgan HouselApr 29, 2026
Finance
Understanding SEC Form S-4: Mergers, Acquisitions, and Stock Offerings
SEC Form S-4 is a crucial document filed by public companies with the U.S. Securities and Exchange Commission (SEC) to disclose details regarding mergers, acquisitions, or stock exchange offers. This form ensures transparency and regulatory compliance by providing comprehensive information about the transaction terms, risk factors, financial data, and other critical details to investors and the public. Its purpose is to uphold market integrity during significant corporate restructuring events.
By Lisa JingApr 29, 2026